CN Stock MarketDetailed Quotes
002399 Shenzhen Hepalink Pharmaceutical Group
- 10.13
- -0.20-1.94%
Not Open Jan 8 15:00 CST
14.86BMarket Cap-101.30P/E (TTM)
10.38High9.97Low40.98KlotVolume10.30Open10.33Pre Close41.62MTurnover0.33%Turnover RatioLossP/E (Static)1.47BShares12.5452wk High1.22P/B12.63BFloat Cap6.8952wk Low11.36Limit Up1.25BShs Float56.04Historical High9.30Limit Down3.97%Amplitude6.89Historical Low--Dividend TTM10.15Avg Price20.56KlotAsk--Div YieldTTM100Lot Size19.50KlotBid
Shenzhen Hepalink Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -6.61%4.3B | -10.34%2.86B | -17.18%1.49B | -17.99%6.09B | -18.32%4.6B | -13.52%3.19B | 0.31%1.8B | 13.30%7.43B | 19.89%5.64B | 19.82%3.69B |
| Refunds of taxes and levies | -11.67%182.82M | -2.18%147.33M | 9.62%74.09M | -44.96%285.54M | -44.87%206.97M | -50.50%150.62M | -42.55%67.59M | 42.03%518.81M | 35.59%375.42M | 121.13%304.28M |
| Cash received relating to other operating activities | 183.31%135.39M | 180.77%107.91M | 47.78%97.38M | -30.29%61.81M | -33.63%47.79M | 27.12%38.43M | 34.10%65.89M | 70.00%88.68M | 100.03%72.01M | 7.60%30.23M |
| Cash inflows from operating activities | -4.95%4.62B | -7.80%3.12B | -14.03%1.66B | -19.87%6.44B | -20.14%4.86B | -16.01%3.38B | -1.41%1.94B | 15.23%8.04B | 21.33%6.08B | 24.01%4.02B |
| Goods services cash paid | -59.34%1.48B | -69.89%887.97M | -78.37%358.34M | -40.73%4.1B | -31.75%3.63B | -11.89%2.95B | 7.61%1.66B | 28.48%6.92B | 46.82%5.32B | 55.97%3.35B |
| Staff behalf paid | -17.18%557.64M | -18.40%386.4M | -12.94%182.06M | 2.06%774.86M | -6.10%673.35M | 12.20%473.53M | 10.21%209.13M | 11.79%759.18M | 22.49%717.09M | 2.46%422.04M |
| All taxes paid | 32.92%279.42M | 75.39%192.73M | 21.44%61.14M | 12.35%278.64M | -0.46%210.22M | -16.31%109.89M | -8.94%50.34M | 5.12%248M | 14.05%211.19M | 7.97%131.3M |
| Cash paid relating to other operating activities | -11.22%511.07M | -9.30%354.66M | -22.04%182.65M | 2.58%884.44M | 4.32%575.64M | 6.90%391.03M | 29.55%234.29M | 27.35%862.16M | 11.42%551.8M | 21.52%365.79M |
| Cash outflows from operating activities | -44.51%2.83B | -53.56%1.82B | -63.53%784.19M | -31.29%6.04B | -25.15%5.09B | -8.03%3.92B | 9.41%2.15B | 25.96%8.79B | 39.08%6.8B | 43.14%4.27B |
| Net cash flows from operating activities | 865.91%1.79B | 338.57%1.29B | 511.47%880.45M | 152.63%398.22M | 67.47%-233.99M | -125.45%-542.75M | -15,418.93%-213.98M | -11,313.12%-756.61M | -686.10%-719.28M | -190.63%-240.74M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -23.14%1.15B | -32.33%964.21M | -64.11%423.55M | -61.38%1.57B | -39.48%1.49B | 2.99%1.42B | 89.85%1.18B | 50.04%4.08B | 1.77%2.47B | -16.79%1.38B |
| Cash received from returns on investments | 892.18%320.92M | 396.43%123.14M | -32.71%13.37M | -45.84%73.17M | -65.58%32.34M | -24.25%24.8M | 310.77%19.86M | -77.05%135.11M | -84.01%93.98M | -94.13%32.75M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 20.25%2.79M | 487.14%2.73M | -78.81%21.38K | -7.64%2.34M | 1,430.35%2.32M | 211.05%465.72K | 12.01%100.9K | 47.33%2.53M | -10.87%151.84K | 6,929.32%149.72K |
| Cash received relating to other investing activities | -94.44%42.92M | 426.60%40.93M | -37.30%4.18M | -67.88%775.13M | -61.80%771.78M | -99.39%7.77M | -99.09%6.66M | -17.79%2.41B | 5.79%2.02B | -8.08%1.28B |
| Cash inflows from investing activities | -34.14%1.52B | -22.42%1.13B | -63.44%441.11M | -63.41%2.42B | -49.80%2.3B | -45.92%1.46B | -11.16%1.21B | 6.15%6.63B | -6.91%4.58B | -25.37%2.7B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -48.96%140.27M | -35.68%87.35M | 7.42%60.42M | 100.02%444.88M | 69.06%274.84M | 32.12%135.8M | 57.75%56.25M | 14.73%222.42M | 12.30%162.56M | 17.47%102.78M |
| Cash paid to acquire investments | 111.53%1.44B | 136.18%842.61M | -37.90%220M | -84.89%677.26M | -75.16%683.04M | -79.94%356.77M | -48.00%354.28M | 89.13%4.48B | 82.81%2.75B | 58.42%1.78B |
| Cash paid relating to other investing activities | 403.41%156.65M | 32.81%41M | 6,857.72%30M | -95.15%81.12M | -98.14%31.12M | -96.68%30.87M | -99.94%431.18K | -43.49%1.67B | -25.41%1.67B | -38.77%930M |
| Cash outflows from investing activities | 76.12%1.74B | 85.49%970.96M | -24.46%310.42M | -81.13%1.2B | -78.42%988.99M | -81.38%523.44M | -71.58%410.96M | 15.47%6.38B | 17.87%4.58B | 3.02%2.81B |
| Net cash flows from investing activities | -117.24%-226.22M | -82.87%160.06M | -83.57%130.69M | 388.94%1.22B | 55,654.49%1.31B | 908.77%934.48M | 1,003.94%795.65M | -65.30%249.84M | -99.77%2.35M | -113.09%-115.54M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --192.34K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -35.87%2.28B | -45.93%1.56B | -45.50%826.83M | -24.37%5.11B | -27.83%3.56B | -20.52%2.88B | 6.36%1.52B | 82.90%6.76B | 70.52%4.93B | 151.76%3.63B |
| Cash received relating to other financing activities | -73.70%39.54M | -68.59%34.4M | -89.66%9M | 1,342.66%151.48M | 1,267.04%150.34M | 942.86%109.5M | --87M | --10.5M | --11M | --10.5M |
| Cash inflows from financing activities | -37.40%2.32B | -46.76%1.59B | -47.90%835.83M | -22.25%5.26B | -24.94%3.71B | -17.74%2.99B | 12.46%1.6B | 83.18%6.77B | 70.90%4.94B | 152.49%3.64B |
| Borrowing repayment | -14.48%3.5B | -19.84%2.51B | -11.08%1.43B | -0.74%5.99B | 12.95%4.1B | 43.60%3.13B | 120.25%1.61B | 61.81%6.04B | 23.39%3.63B | 15.75%2.18B |
| Dividend interest payment | -46.83%133.24M | -36.93%93.83M | -39.14%61.11M | 69.67%425.89M | 19.55%250.6M | 1.32%148.78M | 53.25%100.42M | -39.15%251.01M | -45.14%209.61M | 9.27%146.84M |
| Cash payments relating to other financing activities | -6.36%29.74M | -8.30%21.08M | 6.00%12.24M | -64.30%53.42M | -76.03%31.76M | -72.96%22.99M | -7.10%11.55M | 188.67%149.61M | 266.49%132.52M | 193.24%85M |
| Cash outflows from financing activities | -16.27%3.67B | -20.53%2.62B | -12.60%1.51B | 0.53%6.47B | 10.33%4.38B | 36.91%3.3B | 112.88%1.72B | 53.45%6.44B | 18.21%3.97B | 17.84%2.41B |
| Net cash flows from financing activities | -100.26%-1.35B | -235.29%-1.03B | -461.03%-670.83M | -467.20%-1.21B | -169.27%-672.1M | -124.98%-306.84M | -119.39%-119.57M | 165.77%329.56M | 307.43%970.22M | 303.28%1.23B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -68.98%9.87M | -67.15%10.99M | 108.48%2.43M | 110.18%36.32M | 200.62%31.82M | 691.02%33.46M | -194.21%-28.66M | 127.51%17.28M | 138.64%10.59M | 114.43%4.23M |
| Net increase in cash and cash equivalents | -47.53%229.83M | 269.31%437.07M | -20.93%342.74M | 378.84%445.94M | 66.02%438.07M | -86.49%118.35M | -16.26%433.44M | -207.05%-159.93M | -60.32%263.87M | 70.11%876.21M |
| Add:Begin period cash and cash equivalents | 33.79%1.77B | 33.79%1.77B | 33.79%1.77B | -10.81%1.32B | -10.81%1.32B | -10.81%1.32B | -10.81%1.32B | 11.23%1.48B | 11.23%1.48B | 11.23%1.48B |
| End period cash equivalent | 13.52%2B | 53.17%2.2B | 20.26%2.11B | 33.79%1.77B | 0.82%1.76B | -38.96%1.44B | -12.22%1.75B | -10.81%1.32B | -12.61%1.74B | 27.67%2.36B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
